Drug Type Monoclonal antibody |
Synonyms Anti-HER2 Antibody (Biosion), BSI 001, BSI001 |
Target |
Mechanism HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Biosion, Inc.Startup |
Active Organization Biosion, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | CN | Biosion, Inc.Startup | 30 Mar 2022 |
Stomach Cancer | Preclinical | CN | Biosion, Inc.Startup | 30 Mar 2022 |